Last reviewed · How we verify

NCT05396820: KinesioPoint

Adaptation of the Motor System to Experimental Pain

Completed NA Last updated 16 May 2024
What this trial tests

NA trial testing Experimental pain in Kinesiophobia in 30 participants. Completed in 31 October 2023.

Timeline
5 September 2022
Primary endpoint
28 October 2022
31 October 2023

Quick facts

Lead sponsorUniversite du Littoral Cote d'Opale
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment30
Start date5 September 2022
Primary completion28 October 2022
Estimated completion31 October 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Universite du Littoral Cote d'Opale

Who can join

Adults 18 to 65, any sex, with Kinesiophobia or Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to measure the impact of an experimental pain on electromyography, kinematics of motion and motor cortical excitability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pain-Induced changes in corticospinal excitability are associated with adaptive changes in muscle coordination.
    Duport A, Diotalevi G, Morel P, Le Blanc F, et al · · 2026 · PMID 42004785 · DOI 10.1016/j.ynpai.2026.100212

Verify or expand the search:

Other recruiting trials for Kinesiophobia

Currently open trials in the same condition.

Other Universite du Littoral Cote d'Opale trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing